Detalhe da pesquisa
1.
Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal-bolus insulin regimens in treat-to-target trials: A narrative review.
Diabet Med
; : e15339, 2024 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38679910
2.
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial.
Diabetes Obes Metab
; 26(2): 540-547, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37880868
3.
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes.
Diabetes Obes Metab
; 25(5): 1351-1360, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36692230
4.
STREME: accurate and versatile sequence motif discovery.
Bioinformatics
; 37(18): 2834-2840, 2021 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33760053
5.
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study.
Diabetes Obes Metab
; 24(8): 1617-1622, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35491520
6.
T-Gene: improved target gene prediction.
Bioinformatics
; 36(12): 3902-3904, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32246829
7.
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.
Diabetes Obes Metab
; 23(8): 1713-1721, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33881797
8.
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial.
Diabetes Obes Metab
; 23(10): 2329-2335, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34169625
9.
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial.
Pediatr Diabetes
; 22(5): 734-741, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33934456
10.
Defining the RGG/RG motif.
Mol Cell
; 50(5): 613-23, 2013 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-23746349
11.
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
Diabetes Spectr
; 34(4): 407-418, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34866875
12.
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
JAMA
; 325(14): 1403-1413, 2021 04 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33625476
13.
MoMo: discovery of statistically significant post-translational modification motifs.
Bioinformatics
; 35(16): 2774-2782, 2019 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30596994
14.
Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second-generation basal insulin analogues.
Diabetes Metab Res Rev
; 36(7): e3329, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32315508
15.
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
Diabetes Obes Metab
; 22(11): 1995-2003, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32538550
16.
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Diabetes Obes Metab
; 22(11): 2004-2012, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32729217
17.
Homodimerization regulates an endothelial specific signature of the SOX18 transcription factor.
Nucleic Acids Res
; 46(21): 11381-11395, 2018 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30335167
18.
Neural-specific Sox2 input and differential Gli-binding affinity provide context and positional information in Shh-directed neural patterning.
Genes Dev
; 26(24): 2802-16, 2012 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23249739
19.
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naïve cohort study.
Diabetes Obes Metab
; 21(7): 1596-1605, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30843339
20.
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient-level pooled analysis of EDITION 1, 2 and 3.
Diabetes Obes Metab
; 21(3): 715-719, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30414260